{"id":"622972f2-9a1e-58bb-9095-528ae3de8f83","stable_key":"aad5a443-96e9-52eb-963a-812e90f9f896:lycopene-apo-cyclin","predicate":"reduced","statement":"The metabolite lowered cyclin E and inhibited G1-to-S progression in the bronchial-cell models.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"ea3e1356-5eb8-5402-a3cc-55f65783bc22","mechanism_event_label":"A cell-cycle accelerator decreased.","subject":{"id":"09d5d992-0670-5714-9cfc-992c18bbc0dd","slug":"apo-10-lycopenoic-acid","display_name":"Apo-10-prime-lycopenoic acid","entity_type_key":"small_molecule"},"object":{"id":"df7a37bd-9854-5eab-94dc-17438ce62269","slug":"bronchial-cyclin-e-abundance","display_name":"Cyclin E abundance in experimental bronchial cells","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"ea3e1356-5eb8-5402-a3cc-55f65783bc22","stable_key":"aad5a443-96e9-52eb-963a-812e90f9f896:lycopene-apo-cyclin-event","event_type":"biochemical_relationship","label":"A cell-cycle accelerator decreased.","description":"The metabolite lowered cyclin E and inhibited G1-to-S progression in the bronchial-cell models.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"09d5d992-0670-5714-9cfc-992c18bbc0dd","slug":"apo-10-lycopenoic-acid","display_name":"Apo-10-prime-lycopenoic acid","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"df7a37bd-9854-5eab-94dc-17438ce62269","slug":"bronchial-cyclin-e-abundance","display_name":"Cyclin E abundance in experimental bronchial cells","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/lycopene-research/17420169.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c\", \"start_char\": 0, \"end_char\": 1675, \"text_sha256\": \"84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Cell-cycle assays and NNK-induced mouse tumor model","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Lycopene research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"lycopene","display_name":"Lycopene","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human bronchial cell lines; A/J mice separately specified","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"A cell-cycle accelerator decreased.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Bronchial epithelium and lung tumors","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"5c09a0cd-9b2e-57d6-86e7-7426cb17809e","evidence_kind":"source_excerpt","locator":"Lines 715-726","start_line":715,"end_line":726,"excerpt":"### lycopene-apo-cyclin\nThe metabolite lowered cyclin E and inhibited G1-to-S progression in the bronchial-cell models.\nCondition category: normal\nnutrient_topic: Lycopene research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: A cell-cycle accelerator decreased.\norganism: Human bronchial cell lines; A/J mice separately specified\ntissue_or_cell_type: Bronchial epithelium and lung tumors\nexperimental_model: Cell-cycle assays and NNK-induced mouse tumor model\nlimitations: Metabolite exposure, not a clinical lycopene trial; tumor multiplicity is not human survival.\nexposure: Apo-10-prime-lycopenoic acid; mouse diets 10, 40 or 120 mg/kg\nevidence_span: {\"source_cache\": \"artifacts/lycopene-research/17420169.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c\", \"start_char\": 0, \"end_char\": 1675, \"text_sha256\": \"84a4b4088d833621e68106129dcbe8ddda9e743ec613cebdd4ce9cf03daeb15c\"}\n[lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076","model_system":"Cell-cycle assays and NNK-induced mouse tumor model","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [lycopene-p17420169] Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. (2007). https://pubmed.ncbi.nlm.nih.gov/17420169/ DOI: 10.1093/carcin/bgm076","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d1e09874-8bde-548f-9664-26ad5eedb3c7","stable_key":"import-aad5a443-96e9-52eb-963a-812e90f9f896","title":"Lycopene: absorption, metabolism, nutrient connections and human outcomes (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"9a53dd877de8b71d446f741026477c0fd70a38edac89f6f25339a371a627a59a","revision_id":"2e68d88d-a689-5959-9f9c-1552dd089c22","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}